IMNM — Immunome Inc. price, chart and key statistics

Price data

Price

$16.47

YTD price return

-23.32%

YTD total return

-23.32%

Next earnings

Nov 5, 2026

Market cap

1.9B2020-12 103.2M2026-10 1.9B+1712.9% over the window

Enterprise value

1.7B

Shares outstanding

113.6M2019-12 1.1M2026-06 113.6M+10232.1% over the window

52W low

$14.64

52W high

$30.06

From 52W high

-45.21%

From 52W low

+12.50%

52W range

12%

Volume

Rel volume

0.93×

30D volume

1.4M

30D $ vol

30.3M

Fundamentals

EPS (ttm)

-$2.492020-12 -$5.262026-06 -$2.49-52.7% over the window

FCF (ttm)

-219.1M2019-12 -9.8M2026-06 -219.1M+2128.1% over the window

FCF/share

-$1.932019-12 -$8.952026-06 -$1.93-78.4% over the window

Book value/share

$4.622019-12 -$32.412026-06 $4.62-114.3% over the window

ROE

-48.43%2020-12 -43.1%2026-06 -48.4%+12.3% over the window

ROA

-44.98%2019-12 -206.4%2026-06 -45.0%-78.2% over the window

Current ratio

15.082019-12 1.882026-06 15.08+704.1% over the window

Growth (CAGR, ttm) · 10Y

Shares

+30.51%2025-06-30 → 2026-06-3087M → 113.6M (+30.5% total)+110.32%2023-06-30 → 2026-06-3012.2M → 113.6M (+830.8% total)+57.25%2021-06-30 → 2026-06-3011.8M → 113.6M (+861.4% total)n/a

Per-share growth (CAGR, ttm) · 10Y

Book value/share

+49.49%2025-06-30 → 2026-06-30$3.09 → $4.62 (+49.4% total)+82.10%2023-06-30 → 2026-06-30$0.77 → $4.62 (+504.1% total)-2.06%2021-06-30 → 2026-06-30$5.13 → $4.62 (-9.9% total)n/a

Price

-0.12%2025-10-16 → 2026-10-16$16.49 → $16.47 (-0.1% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+22.67%2023-10-16 → 2026-10-16$8.92 → $16.47 (+84.6% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-1.33%2021-10-15 → 2026-10-16$17.61 → $16.47 (-6.5% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.n/a

Total return

-0.12%2025-10-16 → 2026-10-16$16.49 → $16.47 (-0.1% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+22.67%2023-10-16 → 2026-10-16$8.92 → $16.47 (+84.6% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-1.33%2021-10-15 → 2026-10-16$17.61 → $16.47 (-6.5% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.n/a

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.

-6.6×2020-12 -5.782026-10 -7.36+27.1% over the window

Fwd P/E

-8.0×

P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.

3.6×2020-12 2.502026-10 3.56+42.7% over the window

FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.

-11.71%2020-12 -12.3%2026-06 -9.1%-26.2% over the window

Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 113.6M ÷ 87.0M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.

-30.51%

Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (-30.51%) + dividends paid over that year ($0) ÷ market_cap_at(2025-06-30) ($809.5M). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.

-30.51%

Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($-45.9M) ÷ today's market cap ($1.9B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.

-2.45%2020-12 -43.5%2026-06 -1.9%-95.6% over the window

Shareholder yield (cash, ttm)(TTM buybacks net of issuance $-45.9M + TTM dividends $0) ÷ today's market cap ($1.9B). Same caveat as the cash buyback yield.

-2.45%2020-12 -43.5%2026-06 -1.9%-95.6% over the window

Vs own 10Y history

P/B

42nd